Attached files

file filename
EX-99.1 - EX-99.1 - Apollo Endosurgery, Inc.a13-16115_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  July 3, 2013

 

LPATH, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-50344

 

16-1630142

(State or other jurisdiction of
incorporation)

 

(Commission File
Number)

 

(I.R.S. Employer
Identification No.)

 

4025 Sorrento Valley Blvd., San Diego, California 92121

(Address of principal executive offices) (Zip Code)

 

(858) 678-0800

(Registrant’s telephone number, including area code)

 

n/a

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

 

o

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

o

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

o

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

o

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 7.01 Regulation FD Disclosure.

 

On July 3, 2013, Lpath, Inc. (the “Company”) issued a press release (the “Press Release”) announcing that the Company will present at the 2013 JMP Healthcare Conference.

 

A copy of the Press Release is attached to this Current Report on Form 8-K as Exhibit 99.1.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
No.

 

Description

 

 

 

99.1*

 

Press Release, dated July 3, 2013, titled “Lpath to Present at the 2013 JMP Healthcare Conference on July 9”

 


*              Furnished herewith.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

LPATH, INC.

 

 

 

 

 

 

 

Dated: July 3, 2013

By:

/s/ Gary J. G. Atkinson

 

 

Name: Gary J.G. Atkinson

 

 

Title: Senior Vice President and Chief Financial
Officer

 

3



 

Exhibit Index

 

Exhibit
No.

 

Description

 

 

 

99.1*

 

Press Release, dated July 3, 2013, titled “Lpath to Present at the 2013 JMP Healthcare Conference on July 9”

 


*              Furnished herewith.

 

4